Muscarinic receptor agonists that are effective in the treatment of pain, Alzheimer's disease and schizophrenia.
Details for Australian Patent Application No. 2007256012 (hide)
International Classifications
Event Publications
18 December 2008 PCT application entered the National Phase
PCT publication WO2007/142583 Priority application(s): WO2007/142583
15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007256005-2-thioxanthine derivatives acting as MPO-inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser